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In Brief
The cellular origin of basal cell carcinoma
(BCC), the most common cancer, has
been controversial. Here, Peterson et al.
report that BCCs primarily arise from
stem cells within hair follicle and
mechanosensory touch dome epithelia
and further demonstrate that cutaneous
nerves maintain touch dome identity and
promote tumorigenesis.
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Basal cell carcinoma (BCC) is characterized by
frequent loss of PTCH1, leading to constitutive acti-
vation of the Hedgehog pathway. Although the
requirement for Hedgehog in BCC is well estab-
lished, the identity of disease-initiating cells and the
compartments in which they reside remain contro-
versial. By using several inducible Cre drivers
to delete Ptch1 in different cell compartments
in mice, we show here that multiple hair follicle
stem cell populations readily develop BCC-like
tumors. In contrast, stem cells within the interfollicu-
lar epidermis do not efficiently form tumors. Notably,
we observed that innervated Gli1-expressing
progenitors within mechanosensory touch dome
epithelia are highly tumorigenic. Sensory nerves acti-
vate Hedgehog signaling in normal touch domes,
while denervation attenuates touch dome-derived
tumors. Together, our studies identify varying tumor
susceptibilities among different stem cell popula-
tions in the skin, highlight touch dome epithelia as
‘‘hot spots’’ for tumor formation, and implicate cuta-
neous nerves as mediators of tumorigenesis.
INTRODUCTION
Dysregulated Hedgehog (Hh) signaling is a hallmark of basal cell
carcinoma (BCC), the most common cancer in North America
(Epstein, 2008; Kasper et al., 2012). During development and
homeostasis, Hh is carefully regulated by a balance of upstream
factors that can either promote signaling, such as Smoothened
(Smo), or suppress signaling, such as Patched1 (Ptch1). In
BCC, this balance is tilted decisively in favor of pathway activa-
tion through mutations that cause either loss of PTCH1 function
or constitutive activation of SMO (Johnson et al., 1996; Xie et al.,
1998).
Early evidence implicating perturbed Hh in BCC came from
studies demonstrating that patients harboring defective PTCH1
alleles are predisposed to developing numerous BCCs (Gorlin’s
syndrome) (Bonifas et al., 1994; Hahn et al., 1996; Johnson et al.,400 Cell Stem Cell 16, 400–412, April 2, 2015 ª2015 Elsevier Inc.1996). Similarly, loss of Ptch1 promotes BCC-like lesions in irra-
diatedmice (Aszterbaum et al., 1999), as does overexpression of
mutated forms of Smo, Sonic hedgehog, or downstreamGli tran-
scription factors (Grachtchouk et al., 2000; Mao et al., 2006;
Nilsson et al., 2000; Oro and Higgins, 2003; Oro et al., 1997;
Xie et al., 1998). Findings from these and other studies have
recently culminated in the USA Food and Drug Administration’s
approval of GDC-0449 (vismodegib), an oral inhibitor of SMO, as
a therapeutic for treating advanced BCC.
In the skin, multiple stem cell populations maintain tissue
homeostasis and contribute to organ regeneration during hair
cycling (Jaks et al., 2010). In trying to identify the stem cells
that give rise to BCC, however, recent studies have yielded con-
flicting results (Epstein, 2011). For instance, work by Youssef
et al. (2010) has suggested that hair follicle bulge stem cells
expressing a constitutively active form of Smo (SmoM2) resist
BCC formation. Rather, these tumors arise primarily from the
interfollicular epidermis (IFE), which we have also observed in
intact and wounded skin (Wong and Reiter, 2011). In direct
contrast, lineage tracing experiments byWang et al. (2011) using
irradiated Ptch1 heterozygous animals have suggested that
Keratin 15+ bulge stem cells are the primary progenitors for
BCC. A third possibility—that stem cells in the epidermis and
bulge are both competent for tumorigenesis—has also been
proposed for tumors induced by an activated form of Gli2
(Grachtchouk et al., 2011).
These discrepant results are likely due to the use of different
animal models whereby, in some cases, oncogenic transgenes
such as SmoM2 are driven by heterologous promoters. Because
up to 90% of human BCCs are thought to be caused by loss of
PTCH1, mouse models that target deletion of Ptch1 to specific
skin compartments may serve as more accurate models of
human disease. Indeed, deletion of Ptch1 in Lgr5+ stem cells
in the lower bulge and secondary hair germ has been reported
to yield BCC-like tumors (Kasper et al., 2011). Whether other
stem cell populations residing in the hair follicle and IFE possess
tumor-forming capacity currently remains unclear.
Here we demonstrate that multiple hair follicle stem cell pop-
ulations are highly tumorigenic upon deletion of Ptch1, whereas
most stem cells within the IFE do not efficiently form tumors.
However, an innervated subset of IFE cells known as touch
dome (TD) epithelia display activated Hh signaling during
homeostasis and are highly susceptible to tumorigenesis. Surgi-
cal nerve ablation blunted the formation of TD-derived lesions,
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Figure 1. Multiple Hair Follicle Stem Cells Readily Form BCC-like Tumors
(A) Schematic showing areas of activity (blue) for the different inducible Cre recombinases used in this study. Asterisk indicates TD epithelia. Yellow indicates
sebaceous glands.
(B) Hematoxylin and eosin (H&E) staining showing that Gli1;Ptch1mice, but not control animals, develop numerous hair follicle-associated tumors 5 weeks after
tamoxifen (TAM).
(C) Higher magnification views of hair follicle-associated tumors with peripheral palisading (dotted line).
(D) Hes1-CreERT2-mediated recombination of a floxed YFP reporter allele (green) in suprabasal cells of the epidermis, infundibulum, and, less frequently, in the
bulge, 3 days (left) or 50 days (right) post-TAM.
(E) Hes1;Ptch1 mice develop bulge-associated tumors, 7 weeks post-TAM. (Right) A higher magnification view of the region indicated by the asterisk.
(F) Lrig1;Ptch1 mice develop tumors associated with the isthmus and infundibulum, 5 weeks post-TAM.
The scale bars represent 50 mm. See also Figure S1.suggesting that cutaneous sensory nerves may play a previously
unrecognized role in skin cancer.
RESULTS
BCC-like Tumors Can Arise from Multiple Hair Follicle
Stem Cell Populations
A hair follicle origin for BCC has long been suggested on the ba-
sis of similarities in marker expression (Jih et al., 1999; Schirren
et al., 1997). Because the hair follicle is maintained by several in-
dependent stem cell populations, we directly tested whetherthese cells are able to form tumors upon loss of Ptch1. To target
Ptch1 deletion to specific hair follicle compartments, we gener-
ated mice harboring homozygous Ptch1 floxed alleles (Nitzki
et al., 2012) coupled with different tamoxifen-inducible Cre
drivers (Figure 1A). We treated mice with tamoxifen at 7.5 weeks
of age, then harvested skin biopsies several weeks post-induc-
tion to assess tumor formation.
During telogen, stem cells expressing the Hh target gene Gli1
reside within the hair follicle upper and lower bulge and second-
ary hair germ (Brownell et al., 2011). In mice expressingGli1 pro-
moter-driven CreERT2 and Ptch1 floxed alleles (Gli1;Ptch1), weCell Stem Cell 16, 400–412, April 2, 2015 ª2015 Elsevier Inc. 401
observed robust tumor formation 5 weeks after tamoxifen induc-
tion (Figure 1B). These tumors appeared well circumscribed and
displayed BCC-like features such as peripheral basal palisading
(Figure 1C). As expected, these lesions were typically connected
to the hair follicle upper and lower bulge, but not the infundib-
ulum, consistent with the lack of contribution of Gli1+ stem cells
to the hair canal (Brownell et al., 2011). Although Gli1+ cells can
contribute to regenerating hair follicles during anagen, we did not
observe tumors associated with the lower anagen follicle, sug-
gesting that matrix cells cannot give rise to BCCs (Figure S1).
We have recently reported that mice expressing Hes1 pro-
moter-driven CreERT2 display recombinase activity in suprabasal
cells of the IFE and infundibulum (Veniaminova et al., 2013). By
coupling this recombinase with an inducible ROSA26R pro-
moter-driven YFP reporter allele, we also observed Cre activity
in inner bulge and, less frequently, in outer bulge stem cells (Fig-
ure 1D). We therefore assessed tumor formation in mice ex-
pressing this Cre along with Ptch1 floxed alleles (Hes1;Ptch1),
and observed upper and lower bulge-associated lesions similar
to those inGli1;Ptch1 animals, within 7 weeks after tamoxifen in-
duction (Figure 1E). Together, these data confirm that bulge stem
cells can indeed serve as tumor progenitors.
To test whether other stem cell populations can form BCCs,
we next focused on Lrig1+ cells in the isthmus. Under homeo-
static conditions, these cells renew the hair follicle infundibulum
independently of bulge stem cells, because bulge cells largely do
not contribute to the infundibulum, while Lrig1+ stem cells do not
contribute to the bulge or anagen follicle (Page et al., 2013; Ven-
iaminova et al., 2013). In mice expressing Lrig1 promoter-driven
CreERT2 and Ptch1 floxed alleles (Lrig1;Ptch1), we observed
numerous tumors associated with the isthmus and infundibulum
5 weeks after tamoxifen induction (Figure 1F). These findings
therefore reveal that BCC-like tumors can originate from upper
bulge, lower bulge, and isthmus progenitor populations in the
hair follicle.
The IFE Displays Reduced Tumor-Forming Capacity
To determine whether the epidermis is susceptible to tumorigen-
esis, we deleted Ptch1 in the IFE using mice expressing Keratin
14 promoter-drivenCreERT (K14;Ptch1). We and others have pre-
viously shown that this recombinase displays robust activity in
the IFE but minimal activity in the hair follicle (Wong and Reiter,
2011; Zhang et al., 2009), as confirmed here using the YFP re-
porter allele (Figure 2A). Surprisingly, K14;Ptch1 mice did not
develop tumors in the epidermis 5 weeks after induction. Even
after extending the interval between tamoxifen treatment and bi-
opsy to 12 weeks, we noticed that K14;Ptch1 animals typically
possessed a hyperplastic epidermis containing small, ectopic
hair follicle-like buds resembling early benign follicular hamarto-
mas (Figure 2B). Larger lesions adjacent to the IFE radiated later-
ally from the hair follicle infundibulum and did not display a
connection to the epidermis, as confirmed by examining serial
sections (Figures 2B and S2).
Previous studies have found that P53 mutations are common
in human BCC and that loss of p53 can promote BCCs in the IFE
of irradiated Ptch1-heterozygous mice (Ponte´n et al., 1997;
Wang et al., 2011). We therefore assessed tumor formation in
K14;Ptch1 mice that additionally harbored homozygous floxed
alleles of p53. In mice biopsied up to 12 weeks after tamoxifen402 Cell Stem Cell 16, 400–412, April 2, 2015 ª2015 Elsevier Inc.treatment, however, we observed that loss of p53 did not
enhance IFE tumorigenesis (Figure 2C). In stark contrast,
Gli1;Ptch1, Hes1;Ptch1 and Lrig1;Ptch1 mice with wild-type
p53 all developed large hair follicle-associated lesions that filled
the dermis within 5 to 7 weeks post-induction (Figure 1). These
findings indicate that BCC-like tumors preferentially develop
from hair follicle stem cells and that loss of p53 does not promote
IFE tumor formation.
Hair Follicle-Derived Tumors Express Similar Markers
Irrespective of Stem Cell Origin
Given our finding that BCC-like lesions can originate from multi-
ple hair follicle stem cell populations, we next determined
whether these tumors display differences in marker expression.
Regardless of cellular origin, all hair follicle-derived tumors
consistently expressed K14 as well as K17, a Hh pathway target
gene (Callahan et al., 2004) (Figures 3A and 3B). K17 was also
upregulated throughout the hyperplastic epidermis of induced
K14;Ptch1 animals, indicating that IFE stem cells which had
deleted Ptch1 remained in the epidermis and activated down-
stream Hh signaling in spite of the absence of tumors.
All hair follicle-derived tumors also expressed the stem
markers Sox9 and Lrig1 (Figures 3C and 3D). At the same
time, these tumors sometimes exhibited signs of early differenti-
ation, as evidenced by expression of K10 (Figure 3E). In contrast,
involucrin, a later differentiation marker, was not observed (Fig-
ure 3F). Because we were ultimately unable to detect differential
marker expression, this suggests that all hair follicle-derived
tumors display a similar phenotype irrespective of cellular origin.
BCC-like Tumors Efficiently Arise from Stem Cells
within Touch Dome Epithelia
Although the IFE was largely devoid of tumors, we noticed that
Gli1;Ptch1 mice frequently developed branched lesions that
radiated down from the epidermis specifically at sites adjacent
to guard hairs (Figure 4A). Because mechanosensory TD
epithelia are localized to guard hairs, we re-evaluated the activity
of Gli1-CreERT2 by generating mice expressing the recombinase
along with either an inducible ROSA26R promoter-driven
b-galactosidase (LacZ) or YFP reporter allele (Gli1;LacZ or
Gli1;YFP, respectively). After tamoxifen induction, these mice
indeed displayed reporter gene expression in TDs, as deter-
mined both by whole-mount staining for LacZ and by co-local-
izing YFP with K17, a marker of TDs (Doucet et al., 2013; Moll
et al., 1993) (Figure 4B). TD labeling was stably maintained in
the long term (Figures 4B and S3), suggesting that TDs are
renewed by dedicated stem cell pools that display Hh pathway
activity during homeostasis.
It is interesting to note that normal TDs typically consist of ker-
atinocytes displaying a columnar basal morphology resembling
the peripheral palisades observed in hair follicle-associated
BCC-like tumors (Figure 4C). To establish that epidermis-associ-
ated Gli1;Ptch1 tumors are derived from TDs, we examined
tumor formation at earlier time points and observed a gradual
lateral as well as downward expansion of K17+ TD-derived cell
clusters upon deletion of Ptch1 (Figures 4D and 4E). Just as
normal TDs are juxtaposed by innervated neuroendocrine
Merkel cells (Moll et al., 2005), epidermis-associated tumors in
Gli1;Ptch1 mice were also lined by Merkel cells, as assessed
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Figure 2. IFE Stem Cells Do Not Efficiently Form Tumors
(A) IHC showing that K14-CreERT induces recombination of a YFP reporter allele (green) primarily in basal IFE cells, as marked by integrin b4 (red).
(B) K14;Ptch1mice develop small ectopic IFE-associated buds, 5 weeks after TAM. By 12 weeks post-TAM, the IFE is hyperplastic but largely devoid of lesions.
Tumors adjacent to the IFE (arrows) are typically connected to hair follicles, as shown in serial sections (Figure S2).
(C) Loss of p53 does not promote IFE tumor formation, 12 weeks post-TAM.
The scale bars represent 50 mm.by staining for the marker K8 (Figure 4D). In addition, neurofila-
ment staining confirmed that tumor-associated Merkel cells
were innervated by sensory afferents (Figure 4F). In contrast,
Merkel cells were never detected near any hair follicle-associ-
ated tumors (Figure 4F).
Infrequently, we also observed more extensive epidermis-
associated lesions in K14;Ptch1mice (Figure 4G). These tumors
resembled those arising from the TD in Gli1;Ptch1 animals, and
staining for K8 confirmed the presence of Merkel cells localized
to these tumors (Figure 4G). To assess whether K14-CreERT can
induce recombination in the TD, we analyzed mice expressing
the recombinase along with the YFP reporter allele (K14;YFP).
Indeed, TD epithelia were occasionally labeled in K14;YFP ani-
mals, although at a frequency that was significantly reduced
compared with either IFE labeling outside of TDs or labeling
within TDs in Gli1;YFP mice (Figures 4H and 4I). DiminishedK14-CreERT activity in the TD is likely due to reduced expression
of K14 in TDs relative to the rest of the IFE, which is apparent only
upon high dilution (1:1,000,000) of an antibody against this
keratin (Figure 4J). Altogether, our findings suggest that TD
epithelia activate Hh signaling during homeostasis and, unlike
the rest of the IFE, are highly susceptible to forming BCC-like
lesions upon loss of Ptch1.
Surgical Denervation Inhibits Tumorigenesis
Surgical nerve ablation has been reported to cause loss of TDs
and Merkel cells in rodent and feline skin (English et al., 1983;
Nurse et al., 1984). To confirm these findings, we denervated
thoracic-level cutaneous nerves to one side of the dorsal midline
in 6-week-old wild-typemice, while leaving the contralateral side
intact as a sham control. After collecting samples 3 or 5 weeks
after surgery, we observed that denervated skin displayed aCell Stem Cell 16, 400–412, April 2, 2015 ª2015 Elsevier Inc. 403
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Figure 3. Hair Follicle-Derived Tumors Express Similar Markers Regardless of Cellular Origin
(A–F) IHC for (A) K14, (B) K17, (C) Sox9, (D) Lrig1, (E) K10, and (F) involucrin (Inv).
Wild-type telogen hair follicles were from 7.5-week-old mice. Gli1;Ptch1 and Lrig1;Ptch1 tumors were collected 5 weeks post-TAM, while Hes1;Ptch1 and
K14;Ptch1 samples were harvested 7 and 12 weeks post-TAM, respectively. Arrows indicate follicles where the bulge is visible. The scale bars represent 50 mm.significant reduction in K17+ TD size and abundance (Figures 5A
and 5B). Merkel cells were lost from denervated skin (Figure 5B),
possibly subsequent to K17 downregulation (Figure S3), while
remaining Merkel cells were frequently not innervated (Fig-
ure 5C). To further assess Hh activity after denervation, we
denervated 6-week-old Gli1;LacZ mice and treated these
animals with tamoxifen 2 weeks after surgery (Figure 5D). Four
days later, we harvested biopsies for LacZ staining and observed
reduced TD labeling compared with intact contralateral control
(Figure 5D). Given that K17 and Gli1 are both downstream tar-
gets of Hh signaling, these findings suggest that cutaneous
nerves are crucial for maintaining Hh pathway activity in the TD
niche.
We next extended these studies to determine whether dener-
vation can inhibit TD-derived tumors in Gli1;Ptch1 mice. To first
confirm that denervation performed subsequent to tamoxifen in-
duction does not affect Gli1-CreERT2 recombinase activity in the404 Cell Stem Cell 16, 400–412, April 2, 2015 ª2015 Elsevier Inc.TD, we induced Gli1;LacZ mice with tamoxifen at 5.5 weeks of
age, then subsequently denervated one side of the dorsal skin
4 days after induction (Figure 6A). Two weeks after nerve abla-
tion, we harvested skin biopsies and observed similar patterns
of LacZ staining in denervated and sham-operated skin (Fig-
ure 6A). Thus, although TD epithelia rely on nerves to activate
Hh (Figures 5B and 5D), nerve ablation and consequent loss of
Hh pathway activity do not immediately affect the abundance
or distribution of already-labeled cells in the TD, which can
persist for weeks without neural input (English et al., 1983; Nurse
et al., 1984).
In Gli1;Ptch1 mice, we used the same approach, inducing
animals with tamoxifen at 5.5 weeks of age and subsequently
denervating one side of the skin (Figure 6B). Two or five weeks
after tamoxifen induction, we harvested biopsies and confirmed
that cutaneous nerves were stably ablated (Figure S4). Although
denervation did not affect tumor growth 2 weeks post-induction,
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Figure 4. TDs Are Hot Spots for Tumor Formation
(A) H&E staining of a TD-associated lesion (asterisk) in Gli1;Ptch1 mice, 5 weeks post-TAM (left). (Right) Higher magnification view of TD-associated lesion.
(B) (Top)Whole-mount LacZ staining of skin fromGli1;LacZmice, 7 days (left) and 50 days (middle) post-TAM. (Right) LacZ staining showing TD labeling. (Bottom)
IHC for YFP (green) and K17 (red) in a TD from a Gli1;YFP mouse, 35 days post-TAM.
(C) Resemblance of TD columnar basal cells with palisading periphery of a Gli1;Ptch1 tumor (dotted lines).
(D) (Top left) IHC of a normal TD, identified by K17 expression (red) and underlying K8+Merkel cells (green). (Right) Tumorigenic TDs fromGli1;Ptch1mice, 2 and
5 weeks post-TAM.
(E) Quantitation of K17+ cells in the IFE and TD size in Gli1;Ptch1 mice or controls, 2 and 5 weeks post-TAM.
(F) (Top) TD-derived K5+ tumor (red) retaining underlying Merkel cells (yellow) associated with nerves, as identified by neurofilament (NF, green). (Bottom) Hair
follicle-associated tumors (red) with nerves in the dermis (green), but no Merkel cells.
(G) K8+ Merkel cells (arrow) are associated with infrequent IFE-derived tumors, suggesting a TD origin. (Inset) Enlarged view.
(H) K14-CreERT displays infrequent recombination in K17+ TD epithelia (red), and frequent recombination in the rest of the IFE, as assessed by YFP reporter
expression (green).
(I) Quantitation of Gli1-CreERT2 and K14-CreERT recombination rates in TD and non-TD IFE. NR, no recombination detected in non-TD IFE in Gli1;YFP mice.
(J) Reduced expression of K14 (red) in TDs overlying Merkel cells (green). The right panel is identical to the left, but with DAPI omitted.
Data are represented as mean ± SEM. The scale bars represent 50 mm.
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Figure 5. Innervation Is Required for Hh Signaling in TDs
(A) IHC of denervated (Den) or sham-operated wild-type skin (Sham) showing TD epithelia (asterisk) and Merkel cells (green), 5 weeks after surgery. (Right)
Magnified views of TD areas (asterisk). Red indicates K17 expression.
(B) Quantitation of the average size of K17+ TDs, as well as the overall abundance of K17+ cells and Merkel cells in the IFE, 3 and 5 weeks after denervation.
Matched sham and denervated data from the same mice are connected by lines.
(C) Denervation causes stable loss of nerve endings (red) from Merkel cells (green), 3 weeks after surgery.
(D) Whole-mount LacZ staining showing that denervation inhibits induction of LacZ reporter expression in Gli1;LacZ mice. T, TAM; B, biopsy.
All superimposed bar graphs depict mean values. The scale bars represent 50 mm. See also Figure S3.we observed a significant inhibition of TD-derived tumors in
denervated skin 5 weeks after tamoxifen treatment (Figures 6B
and 6C). In nine of ten mice, fewer TD-derived tumor cells
were observed within denervated skin, compared with the
contralateral sham control (mean = 81.3 versus 35.3 TD-derived
tumor cells/cm for sham versus denervated skin, respectively;
p = 0.017 by paired Student’s t test). In addition, the number of
Merkel cells associated with these tumors was also reduced
(Figure 6C). This effect was specific to TD-derived tumors, as
nerve ablation did not significantly affect adjacent hair follicle-
associated lesions (Figure 6D), arguing that denervation does
not induce a systemic anti-tumorigenic response.
If epidermis-associated tumors that develop infrequently in
K14;Ptch1 mice are derived exclusively from TDs, denervation
should also prevent BCC-like lesions in these animals. We there-
fore surgically removed the nerves from dorsal back skin in
6-week-old K14;Ptch1 mice, exposed these animals to tamox-
ifen 2 weeks after surgery, and harvested biopsies after an406 Cell Stem Cell 16, 400–412, April 2, 2015 ª2015 Elsevier Inc.additional 5 weeks. Although nerve ablation did not affect K14-
CreERT-mediated recombination in the IFE (Figure 6E), the forma-
tion of rare TD-derived lesionswas attenuated in denervated skin
(mean = 20.7 versus 3.9 TD-derived tumor cells/cm for sham
versus denervated skin, respectively; p = 0.04 by paired
Student’s t test) (Figure 6F). In contrast, the formation of small
ectopic buds along the IFE was unaffected. Together, our find-
ings in K14;Ptch1 and Gli1;Ptch1 mice indicate that epidermis-
associated tumors preferentially arise from TD epithelia and
that sensory nerves promote progression of TD-derived tumors.
The Mechanosensory Niche Promotes Tumorigenesis
How does the perineural microenvironment foster a pro-tumori-
genic niche? Because TDs display heightened Gli1 expression,
we investigated the possibility that paracrine signals released
by nerves can promote canonical Hh signaling in the TD. Inmam-
mals, three Hh ligands—Shh, Dhh, and Ihh—activate the
pathway. After dissecting dorsal root ganglia, where cell bodies
of cutaneous sensory nerves are located, we determined by
qRT-PCR that these nerves express markedly higher levels of
all three Hh ligands compared with skin epithelia (Figure 7A).
These findings are concordant with recent data showing that
neuron-specific loss of Shh causes deterioration of TDs and
Merkel cells in adult mice (Y. Xiao and I. Brownell, personal
communication).
Although the loss of Ptch1may seemingly bypass the require-
ment for Hh ligands to induce pathway activity in TD-derived
tumors, recent studies have shown that Ptch1-deficient skin
upregulates a related protein, Ptch2, which can also bind Hh
ligands and suppress downstream signaling (Adolphe et al.,
2014). Indeed, we confirmed by qRT-PCR that Ptch2 expression
was increased upon deletion of Ptch1 in K14;Ptch1 mice, sug-
gesting that Ptch2 may dampen Hh signaling in tumor-resistant
IFE (Figure 7B).
To further elucidate why different skin compartments vary in
tumor predisposition, we searched for molecular differences
that might distinguish tumor-susceptible hair follicle and TD
compartments, from tumor-resistant IFE. The cell surface glyco-
protein CD200 is a marker of hair follicle stem cells in humans
and may promote immune privilege in various organs (Garza
et al., 2011). CD200 has also recently been found to be enriched
in cells that can initiate BCC (Colmont et al., 2013). In mice,
CD200 is a marker of TD epithelia (Woo et al., 2010), and we
also observed CD200 throughout the hair follicle, but not in the
IFE (Figure 7C). Furthermore, all hair follicle- and TD-derived
tumors strongly expressed CD200, whereas strikingly, CD200
was completely absent from hyperplastic IFE or weakly
expressed in ectopic IFE buds in K14;Ptch1 mice (Figure 7D).
In keratinocytes, either loss of Ptch1 or pharmacological activa-
tion of Hh signaling elevated CD200 (Figures 7E and 7F).
Together, these findings suggest that in tumor-resistant IFE,
loss of Ptch1 only partially activates the Hh signaling program,
leading to upregulation of some target genes (Gli1, Ptch2,
K17), but not others (CD200) (Figures 7B and S5). Within the
TD niche, nerve-derived factors, possibly involving Hh ligands,
may potentiate full pathway activation and tumorigenesis.
Notably, as normal TDs resemble BCCs in terms of basal
columnar morphology as well as elevated baseline expression
of Gli1, K17 and CD200, this once again argues that TDs are
‘‘hot spots’’ in the epidermis that are primed for tumor formation.
DISCUSSION
The precise cellular origin of BCC has been controversial, as
recent studies have seemingly yielded diametrically opposed
results. Whereas SmoM2-induced BCC-like tumors appear to
arise from stem cells in the IFE, but not from the hair follicle bulge
(Wong and Reiter, 2011; Youssef et al., 2010), tumors driven by
loss of Ptch1 have been reported to originate from the bulge and
secondary hair germ, but not the IFE (Kasper et al., 2011; Wang
et al., 2011). Our results are concordant with those of Wang et al.
(2011) and Kasper et al. (2011), although we have identified addi-
tional stem cell populations that are also susceptible to tumori-
genesis. Altogether, using a mouse model that recapitulates
the most common genetic aberration seen in human BCCs,
our findings indicate that these tumors preferentially arise from
stem cells located specifically in the upper bulge, lower bulge/secondary hair germ, isthmus, and TD, but not from IFE stem
cells or transit-amplifying matrix cells (Figure 7G).
What predisposes certain cutaneous epithelia to forming
tumors upon loss of Ptch1? Previous studies have postulated
that degradation of Gli proteins may restrict Hh signaling and
BCC formation in the skin (Huntzicker et al., 2006; Oro and Hig-
gins, 2003). Supportive of this, Grachtchouk et al. (2011) showed
that upon forced activation of downstream Hh signaling, BCC-
like tumors can arise from both hair follicles and IFE. Alterna-
tively, upregulation of Ptch2 in the absence of Ptch1 may also
restrain full Hh pathway activity. Indeed, Adolphe et al. (2014)
recently demonstrated that mice lacking both Ptch1 and Ptch2
develop a more severe hyperplastic and BCC-like invaginating
epidermal phenotype than do mice deficient for Ptch1 alone.
Our findings are concordant with these observations and sug-
gest that tumor-resistant IFE cells become oncogenic only
upon high activation of Hh signaling requiring loss of multiple
redundant inhibitors of the pathway. These data further suggest
that sites in the skin which normally display high level Hh
signaling are likely predisposed to BCC formation and that loss
of Ptch1 alone at these sites is sufficient for tumorigenesis.
Consistent with this concept, we have found that TD epithelia
display activated Hh signaling during homeostasis and are highly
susceptible to forming tumors. Under normal conditions, TDs
function as mechanosensory organs that detect light touch
and transduce signals via underlying Merkel cells to slowly
adapting type 1 sensory afferents (Maksimovic et al., 2014;
Maricich et al., 2009). We have further shown that cutaneous
sensory nerves express Hh ligands and that denervation impairs
Hh activity in the TD and inhibits the progression of TD-derived
tumors. Although these results suggest that nerve endings
secrete Hh ligands to promote TD-derived tumors, it is important
to add, however, that TD-derived tumors did not appear to
respond to a neutralizing antibody generated against Shh (Fig-
ure S6). These results might be explained if multiple Hh ligands
simultaneously promote TD-derived tumors, and tumor inhibition
can be achieved only by complete and sustained impairment of
Hh signaling, as might occur following long-term denervation.
These findings do not rule out the possibility that nerves may
also non-canonically activate downstreamHh signaling via path-
ways such as TGF-b (Nolan-Stevaux et al., 2009). Alternatively,
cutaneous nerves are known to secrete cytokines such as calci-
tonin gene-related peptide as well as substance P, which can
serve functional roles during epidermal development and pathol-
ogy (Lumpkin et al., 2010). Indeed, neural changes are often
observed in patients with psoriasis and atopic eczema, and
nerve removal inhibits the epidermal hyperplasia observed in
experimental models of these diseases (Ostrowski et al., 2011;
Ward et al., 2012).
Our findings complement those of previous studies showing
that nerves can influence tumors in other organs. For instance,
chemical denervation can inhibit tumorigenesis in the stomach
and colon (Polli-Lopes et al., 2003). More recent studies in pros-
tate cancer have found that peritumoral sympathetic nerves
promote tumor growth, while intratumoral parasympathetic
nerves stimulate metastasis (Magnon et al., 2013). In addition,
b-blockers, which interfere with the sympathetic nervous sys-
tem, can delay the progression of various cancers (Lemeshow
et al., 2011). A tumor-modulatory role for nerves has not beenCell Stem Cell 16, 400–412, April 2, 2015 ª2015 Elsevier Inc. 407
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Figure 6. Denervation Inhibits TD-Derived Tumors
(A) Whole-mount LacZ staining of Gli1;LacZ skin, showing that denervation performed after TAM does not have an immediate effect on labeled Gli1-expressing
TD cells (blue), 2 weeks after induction.
(B) IHC showing that denervation performed after TAM induction of Gli1;Ptch1 mice reduces the size and complexity of TD-derived tumors (white dotted lines).
K8+ Merkel cells are labeled green (arrowheads). Yellow dotted lines indicate adjacent guard hairs.
(C) Quantitation of TD-derived tumor cells (left) and Merkel cell abundance (right), 2 and 5 weeks post-TAM. Matched sham and denervated data from the same
mice are connected by lines.
(legend continued on next page)
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described for Merkel cell carcinoma, a rare cancer thought to
originate from Merkel cells, but would not be surprising given
the close association between nerve endings and mechanosen-
sory cells.
In humans, BCCs primarily develop in sun-exposed, hair-
bearing skin. In addition, the majority of tumors (between 57%
and 78%) typically display a nodular phenotype, while only a
minority (15%–16%) present as superficial lesions (Bastiaens
et al., 1998; Scrivener et al., 2002). Interestingly, Grachtchouk
et al. (2011) previously noted in mice that tumors originating
from hair follicles appear nodular, whereas IFE-associated
tumors resemble superficial human BCCs, suggesting that
tumor histologic phenotype can reflect cellular origin. From this
perspective, the high prevalence of nodular human BCCs is
consistent with our finding that hair follicle stem cells likely serve
as the primary progenitors for these tumors. Although our
studies do not exclude the possibility that loss of Ptch1 may
give rise to tumors from the IFE after an extended latency, our
findings also suggest that some human BCCs that appear to
arise from the IFE might actually originate from the TD.
Because Merkel cells are invariably associated with TD-
derived tumors in our studies, we also examined the distribution
of these cells in a limited number of human BCC samples. In four
of ten tumors, we observed clusters of Merkel cells located
within small tumor foci from both superficial and deeper lesions,
but not within larger tumor masses (Figures 7H and S7). These
observations are consistent with a potential mechanosensory
niche for BCC, or possibly even ‘‘micro-niches’’ within the imme-
diately vicinity of innervated Merkel cells, which in humans are
widely distributed not just in TDs, but also throughout the skin
and hair follicles (Lacour et al., 1991). Moreover, these cells are
particularly abundant in glabrous skin (Fradette et al., 1995),
where palmoplantar pits frequently develop in Gorlin’s patients.
Merkel cells have also been observed in a minority of human
BCCs, including a subtype known as fibroepithelioma of Pinkus
(Sellheyer and Nelson, 2011; Sellheyer et al., 2012), but are
more commonly associated with trichoblastoma (Schulz and
Hartschuh, 1997). It remains to be seen whether Merkel cells
play an early supporting role during BCC tumor initiation,
but are subsequently lost as the tumor expands. Further work
will be required to determine whether both Merkel cells and
nerves preferentially associate with specific BCC subtypes, or
possibly early during tumorigenesis, and if so, whether targeting
these niche elements might represent a viable therapeutic
strategy.
EXPERIMENTAL PROCEDURES
Animals
The following mice were used: Gli1tm3(cre/ERT2)Alj (Ahn and Joyner, 2004),
Tg(KRT14-cre/ERT)20Efu (Vasioukhin et al., 1999), Hes1tm1(cre/ERT2)Lcm
(Kopinke et al., 2011), Lrig1tm1.1(cre/ERT2)Rjc (Powell et al., 2012),
FVB.Cg-Tg(KRT1-5-cre)5132Jlj/Mmnc (Berton et al., 2003), Gt(ROSA)
26Sortm1Sor (Soriano, 1999), Gt(ROSA)26Sortm1(EYFP)Cos (Srinivas et al., 2001),
Ptch1tm1Hahn (Uhmann et al., 2007), and Trp53tm1Brn (Marino et al., 2000).(D) H&E and quantitation showing that denervation does not affect the abundanc
(E) IHC and quantitation showing that denervation does not affect K14-CreERT-m
(F) Quantitation showing that denervation inhibits tumor formation in TDs (left), b
All superimposed bar graphs depict mean values. Data are represented as meanMouse Manipulations
For tumor cell-of-origin experiments, animals were induced with tamoxifen at
7.5 weeks of age. For nerve studies, mice were induced and denervated
according to the schedules described in the text. Tamoxifen doses were as
follows: one dose at 5 mg per 40 g body weight forGli1;Ptch1 and Hes1;Ptch1
mice; one dose at 1 mg per 40 g body weight for Lrig1;Ptch1 mice; and three
daily doses, each 1 mg per 40 g body weight, for K14;Ptch1 mice. Skin
biopsies were harvested as previously described (Wong and Reiter, 2011).
Denervation was adapted from previously described procedures (Ostrowski
et al., 2011). Briefly, mice were anesthetized, and a 4.5 to 5 cm incision was
made along the dorsal midline to expose cutaneous nerves on the left side
(T3–12). These were blunt dissected close to their anatomical entry into the
skin, while nerves on the right side were left intact. All studies were performed
in accordance with regulations established by the University of Michigan Unit
for Laboratory Animal Medicine.
Tissue Staining
Biopsies were fixed for 1 hr in cold 3.7% paraformaldehyde, incubated over-
night in 30% sucrose at 4C, before embedding in OCT. Frozen sections were
stained using standard protocols with the following antibodies: anti-K17
(D73C7, 1:1,500, Cell Signaling); anti-K8 (TROMA-I, 1:500, Developmental
Studies Hybridoma Bank); anti-K20 (D409, 1:500, American Research Prod-
ucts); anti-K14 (AF64, 1:1,000,000, Covance); anti-K5 (03-GP-CK5, American
Research Products); anti-GFP/YFP (GFP-1020, 1:2,000, Aves Labs); anti-NF
(C28E10, 1:500, Cell Signaling); anti-b4 (346-11A, 1:500, BD PharMingen);
anti-Sox9 (H-90, 1:150, Santa Cruz Biotechnology); anti-Lrig1 (AF3688, 1:25,
R&D Systems); anti-K10 (PRB-159P, 1:500, Covance); anti-involucrin (PRB-
140C, 1:500, Covance); anti-chromogranin A (24-1113C1, 1:250, American
Research Products); and anti-CD200 eFluor660 (OX90, 1:2,000, eBioscience).
For frozen samples stained for YFP, sections were pre-treated with cold meth-
anol for 5 min prior to blocking. For whole-mount b-gal staining, in situ staining
andqPCR, seeSupplemental Experimental Procedures. Imageprocessingwas
performed using Adobe Photoshop CS6, with the Auto-Blend function applied
tomaximize imagesharpnessacross focalplanes in thesamemicroscopic field.
Quantitation
For TDs and TD-derived tumors, 15 non-consecutive frozen sections
(each 10 mm thick, 1 cm in length) were analyzed. TDs were identified on
the basis of columnar morphology, K17 expression, and association with
K8-expressing Merkel cells. TD size was assessed by counting the number
of K17+ cells within each cluster along 15 cm of skin. TD-derived tumors
were identified on the basis of criteria used for normal TDs, and the total num-
ber of K17+ cells within lesions radiating down from the epidermis was scored.
K17-expressing cells in the infundibulum were excluded (Veniaminova et al.,
2013). K17 expression is absent in normal non-TD IFE. To quantitate hair folli-
cle-associated tumors inGli1;Ptch1mice, wemeasured tumor volumes from 5
non-consecutive frozen sections (10 mm thick, 1 cm in length) for each sam-
ple. We performed immunohistochemistry (IHC) for K17, outlined tumors in
Photoshop, and recorded tumor area in pixels. For quantitating ectopic hair
buds in K14;Ptch1 mice, we counted the number of cell clusters, defined as
consisting of at least three continuous K17+ cells, along the entire IFE.
Human Samples
Human BCCs were obtained with informed consent under institutional review
board (IRB) protocol HUM00042233, in accordance with procedures
approved by the IRB of the University of Michigan Medical School. Tumor
biopsies were processed for paraffin sections and de-identified, and thus
not regulated as per IRB guidelines (exempt IRB protocol HUM00051875).
Statistics
A paired Student’s t test was used to assess significance in experiments in
which denervated and sham-operated, matched skin samples were harvestede of hair follicle-derived tumors.
ediated recombination in the IFE.
ut not the formation of ectopic IFE buds (right) in K14;Ptch1 mice.
± SEM. The scale bars represent 50 mm. See also Figure S4.
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Figure 7. A Mechanosensory Niche Promotes Tumorigenesis
(A) qPCR showing that DRG (blue bars) highly express all 3 Hh ligands (Shh, Dhh, and Ihh) relative to epidermis (yellow bars). K14 and Tubulin b3 (Tubb3) are
specificity controls for skin and neurons, respectively. All values are expressed as fold induction relative to that of DRG (for K14, left y axis) or epidermis (for all
other genes, right y axis).
(B) qPCR showing that K14;Ptch1 mice, relative to non-tumorigenic controls, upregulate Gli1 and Ptch2 in the skin, 5 weeks post-TAM.
(C) IHC showing CD200 expression (red) throughout the hair follicle (left) and TD (right, dotted line), but not in the IFE. (Top right) TD marked by K17 (green) and
CD200, or CD200 alone (bottom right). Strong red staining in the cornified IFE is due to autofluorescence.
(D) (Left) IHC showing that CD200 (red) is highly expressed in hair follicle-derived tumors (blue dotted lines), but weakly expressed in ectopic IFE buds or
hyperplastic IFE (white dotted lines) in K14;Ptch1mice. (Right) IHC showing that CD200 is highly expressed in TD-derived tumors (yellow dotted lines), both 2 and
5 weeks post-TAM, in Gli1;Ptch1 mice. K17 (green) is indiscriminately upregulated in hyperplastic IFE, ectopic IFE buds, and tumors. All bottom panels are
magnified views of the boxed areas.
(E) qPCR showing that keratinocytes harboring K5 promoter-driven constitutive Cre and homozygous Ptch1 flox alleles upregulate canonical Hh target genes as
well as CD200.
(F) qPCR showing that the Smoothened agonist purmorphamine (purm) upregulates CD200 in wild-type keratinocytes.
(legend continued on next page)
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from the same animal. For all other experiments, an unpaired Student’s t test
was used. Calculations were performed at http://www.physics.csbsju.edu/
stats/Index.html.
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